We present a novel series of quinolin-4(1H)-imines as dual-stage antiplasmodials, several-fold more active than primaquine in vitro against Plasmodium berghei liver stage. Among those, compounds 5g and 5k presented low nanomolar IC50 values. The compounds are metabolically stable and modulate several drug targets. These results emphasize the value of quinolin-4(1H)-imines as a new chemotype and their suitable properties for further drug development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jm400246e | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!